These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 11463130)

  • 21. Milnacipran. A review of its use in depression.
    Spencer CM; Wilde MI
    Drugs; 1998 Sep; 56(3):405-27. PubMed ID: 9777315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased serotonin platelet uptake after tianeptine administration in depressed patients.
    Chamba G; Lemoine P; Flachaire E; Ferry N; Quincy C; Sassard J; Ferber C; Mocaër E; Kamoun A; Renaud B
    Biol Psychiatry; 1991 Sep; 30(6):609-17. PubMed ID: 1932408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it possible to be dependent to Tianeptine, an antidepressant? A case report.
    Kisa C; Bulbul DO; Aydemir C; Goka E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):776-8. PubMed ID: 17270334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs. amitriptyline.
    Invernizzi G; Aguglia E; Bertolino A; Casacchia M; Ciani N; Marchesi GF; Nardini M; Rapisarda V
    Neuropsychobiology; 1994; 30(2-3):85-93. PubMed ID: 7800169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of tianeptine in the treatment of psychasthenia. A study versus placebo].
    Grivois H; Deniker P; Ganry H
    Encephale; 1992; 18(5):591-9. PubMed ID: 1340807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of tianeptine in major depressive disorders with or without melancholia.
    Ginestet D
    Eur Neuropsychopharmacol; 1997 Oct; 7 Suppl 3():S341-5. PubMed ID: 9405961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.
    Wilde MI; Plosker GL; Benfield P
    Drugs; 1993 Nov; 46(5):895-924. PubMed ID: 7507038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
    Schruers K; Griez E
    J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of fluoxetine and tianeptine on emotional and eating disorders in postmenopausal women].
    Jałocha W; Walecka-Kapica E; Tomaszewska-Warda K; Chojnacki J; Klupińska G
    Pol Merkur Lekarski; 2014 Jul; 37(217):35-8. PubMed ID: 25154197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxetine: an update of its use in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    Drugs; 2002; 62(4):655-703. PubMed ID: 11893234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.
    Harris MG; Benfield P
    Drugs Aging; 1995 Jan; 6(1):64-84. PubMed ID: 7696780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sertraline: a review of its use in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    Drugs Aging; 2002; 19(5):377-92. PubMed ID: 12093324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tianeptine in the combined treatment of combat related posttraumatic stress disorder.
    Frančišković T; Suković Z; Janović S; Stevanović A; Nemčić-Moro I; Rončević-Gržeta I; Letica-Crepulja M
    Psychiatr Danub; 2011 Sep; 23(3):257-63. PubMed ID: 21963693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of tianeptine and sertraline in three animal models of depression.
    Kelly JP; Leonard BE
    Neuropharmacology; 1994 Aug; 33(8):1011-6. PubMed ID: 7531300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine. A pharmacoeconomic evaluation of its use in depression.
    Wilde MI; Whittington R
    Pharmacoeconomics; 1995 Jul; 8(1):62-81. PubMed ID: 10155603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
    Fawcett J; Barkin RL
    J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials.
    Defrance R; Marey C; Kamoun A
    Clin Neuropharmacol; 1988; 11 Suppl 2():S74-82. PubMed ID: 2902922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spotlight on paroxetine in psychiatric disorders in adults.
    Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
    CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical profile of tianeptine, a new antidepressant drug.
    Kato G; Weitsch AF
    Clin Neuropharmacol; 1988; 11 Suppl 2():S43-50. PubMed ID: 3052825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.